A260660 Stock Overview
Engages in the researches and develops, produces, and sells medicines in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
Korea Arlico Pharm Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩3,490.00 |
| 52 Week High | ₩6,090.00 |
| 52 Week Low | ₩3,290.00 |
| Beta | 0.74 |
| 11 Month Change | -7.06% |
| 3 Month Change | -21.75% |
| 1 Year Change | -39.62% |
| 33 Year Change | -46.96% |
| 5 Year Change | -58.20% |
| Change since IPO | -76.61% |
Recent News & Updates
Korea Arlico PharmLtd (KOSDAQ:260660) Is Carrying A Fair Bit Of Debt
Nov 12
There's Reason For Concern Over Korea Arlico Pharm Co.,Ltd.'s (KOSDAQ:260660) Price
Aug 04Recent updates
Korea Arlico PharmLtd (KOSDAQ:260660) Is Carrying A Fair Bit Of Debt
Nov 12There's Reason For Concern Over Korea Arlico Pharm Co.,Ltd.'s (KOSDAQ:260660) Price
Aug 04Is Korea Arlico PharmLtd (KOSDAQ:260660) Using Too Much Debt?
Mar 24Should You Be Adding Korea Arlico PharmLtd (KOSDAQ:260660) To Your Watchlist Today?
Mar 02Korea Arlico PharmLtd's (KOSDAQ:260660) Shareholders Are Down 50% On Their Shares
Feb 12
What Is The Ownership Structure Like For Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)?
Jan 25Should You Use Korea Arlico PharmLtd's (KOSDAQ:260660) Statutory Earnings To Analyse It?
Jan 04Is Korea Arlico PharmLtd (KOSDAQ:260660) A Risky Investment?
Dec 16Are Strong Financial Prospects The Force That Is Driving The Momentum In Korea Arlico Pharm Co.,Ltd.'s KOSDAQ:260660) Stock?
Nov 25Shareholder Returns
| A260660 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 2.6% | -1.4% | 1.9% |
| 1Y | -39.6% | 5.3% | -2.6% |
Return vs Industry: A260660 underperformed the KR Pharmaceuticals industry which returned 5.3% over the past year.
Return vs Market: A260660 underperformed the KR Market which returned -2.6% over the past year.
Price Volatility
| A260660 volatility | |
|---|---|
| A260660 Average Weekly Movement | 5.4% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 11.6% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A260660 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A260660's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | n/a | Hang-Gu Lee | www.arlico.co.kr |
Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea. It offers ETC, OTC, medical device, and other products; and active ingredients.
Korea Arlico Pharm Co.,Ltd. Fundamentals Summary
| A260660 fundamental statistics | |
|---|---|
| Market cap | ₩53.26b |
| Earnings (TTM) | -₩8.86b |
| Revenue (TTM) | ₩178.83b |
0.3x
P/S Ratio-6.0x
P/E RatioIs A260660 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A260660 income statement (TTM) | |
|---|---|
| Revenue | ₩178.83b |
| Cost of Revenue | ₩81.95b |
| Gross Profit | ₩96.88b |
| Other Expenses | ₩105.74b |
| Earnings | -₩8.86b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -578.39 |
| Gross Margin | 54.18% |
| Net Profit Margin | -4.96% |
| Debt/Equity Ratio | 57.0% |
How did A260660 perform over the long term?
See historical performance and comparisonDividends
3.7%
Current Dividend Yieldn/a
Payout RatioDoes A260660 pay a reliable dividends?
See A260660 dividend history and benchmarks| Korea Arlico PharmLtd dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Apr 14 2025 |
| Days until Ex dividend | 30 days |
| Days until Dividend pay date | 138 days |
Does A260660 pay a reliable dividends?
See A260660 dividend history and benchmarks